Results

Total Results: 3,709 records

Showing results for "design sample size".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
    February 01, 2014 - Type of Study Included studies with any sample size that met all other criteria.
  2. integrationacademy.ahrq.gov/products/topic-briefs/community-engagement-for-whole-person-care
    February 01, 2025 - Design the electronic medical record notes and reports to track parental goals, interventions provided … Results Staff were initially hesitant to adopt the new program design. … Early implementation was stressful because the new program design was unfamiliar and different from the
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
    May 01, 2022 - The decision to update meta-analyses from the original report was based on the number and sample sizes … Exclusion reason: Ineligible study design 73. Jacobus D, Mehr S, Ziccardi V. … Exclusion reason: Ineligible study design 75. Javaid S, Shafi M, Lodhi Y. … Exclusion reason: Ineligible study design 81. Kim MG, Kim MY. … Exclusion reason: Ineligible study design 155. Tobias AF, Moura EC, Honda CA, et al.
  4. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
    January 15, 2002 - absolute risk of hemorrhagic stroke did not vary significantly according to preexisting CVD, mean age, samplesize, dosage of aspirin, or study duration, although the statistical power to detect such differences
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
    January 01, 2002 - absolute risk of hemorrhagic stroke did not vary significantly according to preexisting CVD, mean age, samplesize, dosage of aspirin, or study duration, although the statistical power to detect such differences
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
    November 01, 2007 - Study Design We conducted a retrospective cohort study with outcomes up to 12 months following discharge … Strengths and Limitations Our study had several strengths including the relatively large sample size … However, while an even larger sample size with additional geographic and practice pattern diversity … Significance Objectives of the Study Methods Settings Human Subjects Review Participants Study Design
  7. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/ambulatory-surgery/sections/ambulatory-surgery-report.pdf
    May 01, 2017 - ongoing quality improvement, demonstrate how the checklist can improve teamwork and communication, and design
  8. www.uspreventiveservicestaskforce.org/home/getfilebytoken/abTWXPvJyAMcqN9KcEt-vt
    September 06, 2016 - Extraction and Quality Assessment For each included study, one investigator extracted information about design … No full text 8 Ineligible setting 267 Ineligible population(s) 15 Poor quality 36 Ineligible study design … unlikely to be clini- cally relevant and can be explained by the number of included stud- ies with large samplesizes and precise estimates, a phenomenon that has been described as producing elevated I2 estimates … Study concept and design: Kahwati, Feltner, Halpern, Jonas.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
    January 30, 2020 - are described in a PICOTSSO (population, intervention, comparator, outcomes, timing, setting, study design … publications reporting on the study, type of publication (journal manuscript, trial record), study design … To make applicability information useful, the review will address how specific aspects of study design … Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review … Therefore, study 24 questions, design, and methodological approaches
  10. www.uspreventiveservicestaskforce.org/home/getfilebytoken/2XRG8Dz2EegVWYUrRThgmD
    October 01, 2015 - that any new trials would have little bearing on the overall results of our synthesis, regard- less of samplesize or effect estimates. … eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design … Author Contributions: Conception and design: C.D. Patnode. … There are relatively more (or equal) included studies of the ideal study design compared with other reviews
  11. hcup-us.ahrq.gov/db/nation/nis/APS-Def_Public_v24.pdf
    March 01, 2008 - ___APS-Def_Public.book 4 0 0 C a p i t a l B o u l e v a r d • R o c k y H i l l , C T 0 6 0 6 7 • 1 - 8 0 0 - 9 9 9 - 3 7 4 7 D e f i n i t i o n s M a n u a l PUB 3.3.2008 APS-DRGs® ALL-PAYER SEVERITY-ADJUSTED DRG (APS-DRGS®) ASSIGNMENT FOR PUBLIC USE VERSION 24 COPYRIGHT PAGE Copyright © 2008 I…
  12. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/archived-webinars/ed-catheter-insertions-transcript.doc
    September 10, 2013 - If you can break this out by a physician, if you have a large enough sample size, if you have the ability
  13. www.ahrq.gov/hai/cauti-tools/archived-webinars/ed-catheter-insertions-transcript.html
    December 01, 2017 - If you can break this out by a physician, if you have a large enough sample size, if you have the ability
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
    May 01, 2013 - for this Key Question, which received a high risk of bias rating due to methodologic limitations in design … and reporting, sample size, and the absence of a control group. … There was significant heterogeneity among the included studies in design and eligibility, and inconsistency
  15. digital.ahrq.gov/sites/default/files/docs/page/privacy-and-security-solutions-for-interoperable-hie-avas-executive-summary.pdf
    June 30, 2007 - Privacy and Security Solutions for Interoperable Health Information Exchange - Assessment of Variation and Analysis of Solutions - Executive Summary June 30, 2007 Privacy and Security Solutions for Interoperable Health Information Exchange Assessment of Variation and Analysis of Solutions Executive…
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-3-acute-pain.pdf
    June 01, 2022 - 1 and 2, the decision to update meta-analyses from the original report was based on the number and samplesizes of new studies eligible for meta-analysis (meta-analysis performed if new evidence was large … Exclusion reason: Ineligible study design 103. Jacobus D, Mehr S, Ziccardi V. … Exclusion reason: Ineligible study design 105. Javaid S, Shafi M, Lodhi Y. … Exclusion reason: Ineligible study design 115. Kim MG, Kim MY.
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/mk-eb9VtB_jx885wnjuzk3
    January 01, 2024 - Data Abstraction and Quality Assessment One investigator abstracted details about the study design, patient … Wrong population 56 Not original studyd 46 Wrong outcomes 45 Wrong publication typee 39 Wrong study design
  18. Spotlight (pdf file)

    psnet.ahrq.gov/sites/default/files/2021-09/spotlight_lost_in_transitions_of_care_09.22.2021_final.pdf
    January 01, 2021 - Spotlight Spotlight Lost in Transitions of Care: Managing an Opioid-Dependent Patient with Frequent Hospitalizations Source and Credits • This presentation is based on the September 2021 AHRQ WebM&M Spotlight Case o See the full article at https://psnet.ahrq.gov/webmm o CME credit is available o Commentary …
  19. psnet.ahrq.gov/web-mm/lost-transitions-care-managing-opioid-dependent-patient-frequent-hospitalizations
    October 27, 2022 - SPOTLIGHT CASE Lost in Transitions of Care: Managing an Opioid-Dependent Patient with Frequent Hospitalizations Citation Text: Tan F, Johl K, Kotova M. Lost in Transitions of Care: Managing an Opioid-Dependent Patient with Frequent Hospitalizations. PSNet [internet]. Rockville (MD): Agency for He…
  20. www.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/qdr-blackhealth-slides.html
    November 01, 2020 - Numbers of measures differ across groups because of sample size limitations.